Event preview: BIO-Europe returns to Hamburg

Supported by regional hosts, the northern Germany biomedical cluster organisation Life Science Nord, the City of Hamburg, and the State of Schleswig-Holstein, BIO-Europe 2019 is expected to bring together 4,400 executives from more than 2,300 life sciences companies from more than 60 countries.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

J&J unit win shuts door on Sandoz generic launch

10 September 2026 Four patents stood firm in a Johnson & Johnson unit’s fight with Sandoz, leaving the generics maker facing a lengthy wait before its esketamine nasal spray can reach the US market.

Pharma

Italy’s Biofer falls short in Fed Circ appeal over key claim wording

7 September 2026 A single phrase in a patent has proved decisive in Biofer’s infringement fight with Vifor, with the Federal Circuit exposing the risks of small claim-drafting choices for life sciences companies.

Pharma

Teva faces scrutiny over efforts to curb generic competition

27 August 2026 Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers.

More features

Built to be bought? What makes companies acquisition-ready

J&J unit win shuts door on Sandoz generic launch

Italy’s Biofer falls short in Fed Circ appeal over key claim wording

10x Genomics wins latest round in Parse patent dispute

Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win

Pinsents expands German patent practice with partner duo

Tempus AI bid to derail DNA patent case hits snag

Teva faces scrutiny over efforts to curb generic competition

Event preview: BIO-Europe returns to Hamburg

More on this story

Editor's picks

Editor's picks

More features